Total Funding
80
11
Total FundingVenture - Series Unknown raised
Growth Score
-10 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1305047
Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.
Acquired by 
ViroPharma
Ira Kalfus: Vice President- Judson A. Cooper: Co-founder
About the Company
Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008,
Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.
